Giralt, S <br/><br/>
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.  [electronic resource] 

 -  Blood  Jun 1997 
 - 4531-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Diseases--chemically induced<br/>Cladribine--administration & dosage<br/>Combined Modality Therapy<br/>Cytarabine--administration & dosage<br/>Feasibility Studies<br/>Female<br/>Filgrastim<br/>Graft vs Host Reaction<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Idarubicin--administration & dosage<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--drug therapy<br/>Pilot Projects<br/>Recombinant Proteins<br/>Remission Induction<br/>Salvage Therapy<br/>Treatment Outcome<br/>Vidarabine--administration & dosage